| 97.036 |
Covid-19 - Federal Emergency Management Agency Disaster Relief Fund |
$88.48M |
| 84.268 |
Federal Direct Student Loans - Hackensack Meridian School of Medicine |
$27.66M |
| 21.027 |
Covid-19 - Coronavirus State Fiscal Recovery Fund |
$26.04M |
| 93.855 |
Covid-19 - Metropolitan Antiviral Drug Accelerator |
$23.91M |
| 21.027 |
Covid-19 - Coronavirus State Fiscal Recovery Fund Project 2024 |
$10.44M |
| 84.268 |
Federal Direct Student Loans - Jfk Muhlenberg School |
$3.41M |
| 93.310 |
Enriching Echo Cohorts with High-Risk Pregnancies and Children with Disabilities (enriching Echo) |
$3.06M |
| 84.181 |
Services: Early Intervention System, Special Education Grants for Infants and Families |
$2.84M |
| 93.855 |
Center to Develop Therapeutic Countermeasures to High-Threat Bacterial Agents |
$2.79M |
| 93.378 |
Integrated Care for Kids Model |
$2.32M |
| 93.855 |
Harnessing B Cells for Tb Vaccine Development to Improve Therapy of Tb and Tb-Hiv Coinfection |
$1.12M |
| 84.063 |
Federal Pell Grant Program - Jfk Muhlenberg School |
$1.06M |
| 93.855 |
Optimization of Rifamycins to Overcome Intrinsic Resistance of Nontuberculous Mycobacteria to Improve Treatment of Ntm Lung Disease |
$1.02M |
| 93.493 |
Community Project Funding/congressionally Directed Spending ‐ Construction |
$777,702 |
| 93.396 |
Identifying and Characterizing Functional Noncoding Mutations in Multiple Myeloma |
$717,876 |
| 93.393 |
Leveraging Social Media to Increase Lung Cancer Screening Awareness, Knowledge |
$683,620 |
| 93.839 |
Dot1l, Reconstitution of Plasmacytoid Dendritic Cells and Alloimmunity |
$649,622 |
| 93.396 |
Id3 Regulation of Tissue-Infiltrating T Cells Mediating Graft-Versus-Host Disease and Leukemia Rejection |
$616,267 |
| 93.855 |
Tcf1 Programs Cd8 T Cell Responses to Enhance Viral and Cancer Immunity |
$609,369 |
| 93.917 |
Hiv Care Formula Grants - Ryan White Part B |
$609,132 |
| 93.855 |
Translational Approaches to Improve Understanding and Outcome in Tuberculous Meningitis |
$602,403 |
| 93.243 |
Icare Integrated Care for Addiction Recovery Expansion |
$590,817 |
| 93.855 |
Immunometabolic Regulations of Pulmonary Tb Pathogenesis by Adipose Tissue |
$587,073 |
| 93.855 |
Determinants of Tb Control, Relapse and Reinfection |
$581,494 |
| 93.396 |
Harnessing the Thymus for Long-Term Tumor Control with Hematopoietic Stem Cell-Derived Naïve Car T Cells |
$539,249 |
| 93.855 |
Transmission Aerobiology of M. Tuberculosis: Genes and Metabolic Pathways That Sustain Mtb Across An Evolutionary Bottleneck |
$470,789 |
| 93.855 |
Critical Factors Influencing Echinocandin Resistance in Candida Glabrata |
$460,594 |
| 93.855 |
Hx Nih Ctcf in Cd8 Tcell |
$459,836 |
| 12.420 |
Mechanisms of Impaired Swallowing, Speech, and Voice in Parkinson's Disease |
$390,082 |
| 93.396 |
Nuclear Envelope and Predisposition to Hepatic Neoplasia |
$387,071 |
| 16.045 |
Project Heal: Expansion of Community-Based Violence Intervention & Prevention Initiatives |
$380,774 |
| 16.575 |
Community-Based Violence Intervention Program |
$380,567 |
| 93.396 |
Study of the Il-33-Driven Immune Cell Organization Underpinning Responses to Immune Checkpoint Blockade Cancer Therapy |
$380,562 |
| 93.433 |
Nidilrr Disability and Rehab. Research Projects Tbi Model Systems |
$371,259 |
| 93.855 |
Discovery of Novel Lead-Target Pairs and Identification of All-Oral Bactericidal Drug Regimens for Mycobacterium Abscessus Lung Disease |
$353,480 |
| 93.855 |
Antibacterial Resistance Leadership Group (arlg) |
$327,571 |
| 93.865 |
Epigenetics of Down Syndrome |
$304,473 |
| 93.855 |
Novel Bi-Specific Immunotherapeutic Against High-Threat Gram-Negative Pathogens |
$302,666 |
| 93.110 |
Pediatric Mental Health Care Access Program 2024 |
$301,058 |
| 93.855 |
Lesion Pharmacokinetics and Pharmacodynamics to Design New Drugs and Drug Combinations for Tuberculosis |
$299,454 |
| 93.273 |
Peptide Therapy for Alcohol-Induced Cns Injury |
$265,919 |
| 93.855 |
A Dual-Beta-Lactam Strategy for Treating Multidrug Resistant M Abscessus |
$252,357 |
| 93.855 |
Preclinical Design and Clinical Translation of Tb Regimens (predistr) Consortium |
$249,603 |
| 93.398 |
Leveraging Behavioral Science to Improve Patient Understanding of Advanced Cancer |
$241,714 |
| 93.398 |
Elucidating the Role of Smad4 in Colorectal Cancer |
$235,765 |
| 93.853 |
Neutrophil Extracellular Traps and Associated Pathogenesis in Tbi: A Novel Peptide Therapeutic Strategy |
$225,448 |
| 93.855 |
Elucidating Mediators of Genetic Instability in Candida Glabrata |
$222,589 |
| 93.855 |
Identifying Drug-Resistant Candida Species Using Superselective Primer Pcr |
$219,703 |
| 93.855 |
Celiac and Inflammatory Bowel Disease: Functional Post-Gwas Approach |
$217,443 |
| 12.420 |
Therapeutic Implications of Tnbc-Specific Etv6 Rearrangements: Chemoresistance and Immune Evasion |
$210,371 |
| 93.398 |
Experimental Evolution of Pancreatic Cancer |
$206,970 |
| 93.247 |
Ane- Nurse Practitioner Residency Program |
$201,375 |
| 93.395 |
Study of Interleukin 33 As A New Immunotherapy of Lung Cancer |
$195,983 |
| 93.397 |
Georgetown Lccc Ccsg |
$192,327 |
| 93.914 |
Ryan White Services for People Living with Hiv |
$185,783 |
| 93.924 |
Ryan White Hiv/aids Dental Reimbursements |
$177,751 |
| 93.397 |
Epigenetic Therapies - New Approaches, Project 1 |
$167,429 |
| 11.617 |
Dna Research Sequence Project |
$167,339 |
| 93.855 |
Novel Strategies for Antibiotic Combinations to Combat Gram-Negative Superbugs |
$165,630 |
| 93.590 |
Community Prevention Direct Service |
$164,829 |
| 93.870 |
New Jersey Home Visiting Initiative: Parents As Teachers |
$152,676 |
| 93.393 |
Using A Mixed Methods Approach to Understand Shared Decision-Making in Lung Cancer Screening |
$144,520 |
| 93.121 |
Dissecting Cell Composition and Drug Sensitivity in Humanadenoid Cystic Carcinomas (accs) |
$140,352 |
| 93.914 |
Ryan White |
$136,025 |
| 93.395 |
Targeting Transcriptional CO-Repressor Corest Complex in Melanoma |
$125,276 |
| 93.838 |
Clock (collaborative Long-Term Study of Outcomes of Covid-19 in Kids) Consortium for Pasc Phase II Recover Pediatric Cohort |
$124,264 |
| 93.243 |
Substance Abuse and Mental Health Services - Projects of Regional and National Significance |
$122,061 |
| 12.420 |
Biomarkers and Pathogenesis of Cutaneous Fibrosis |
$121,666 |
| 93.394 |
Molecular Markers of Risk of Subsequent Invasive Breast Cancer in Women |
$119,182 |
| 10.331 |
Hackensack Meridian Health Fresh Match Initiative (hmhfm) |
$117,572 |
| 93.853 |
Comparing Treatment Approaches to Promote Inpatient Rehabilitation Effectiveness for Traumatic Brain Injury (care 4 Tbi) |
$117,255 |
| 93.855 |
A Preclinical Program for Targeting Mycobacterium Tuberculosis Kasa |
$112,605 |
| 93.393 |
Tmem, Menacalc, and Menainv As Prognostic and Predictive Markers for Breast Cancer Metastasis |
$112,126 |
| 93.243 |
Hmh Carrier Clinic Mental Health Awareness in Identifying Disturbances in Emotions Program (aide) |
$107,308 |
| 93.393 |
Population-Based Assessment of Patient-Reported Outcomes in Adults Living with Metastatic Colorectal Cancer |
$98,550 |
| 12.420 |
Role of Core-Binding Factor Rearrangements in Triple-Negative Breast Cancer Progression and Immune Evasion |
$97,528 |
| 93.393 |
Dissemination of A Breast Reconstruction Decision Tool Through Social Media and Online Communities |
$95,108 |
| 93.110 |
Pediatric Mental Health Care Access Program 2025 |
$93,499 |
| 93.855 |
Within-Host Diversity of Gram Negative Bacteria From Bloodstream Infections |
$89,058 |
| 93.398 |
Optimizing Adherence to Lung Cancer Screening: Applying Theory and Implementation Science to Participant Engagement |
$88,688 |
| 93.991 |
Childhood and Adult Asthma Program 2024 |
$87,238 |
| 97.025 |
Nj-Tf1 Deployment Tropical Cyclone Helene |
$84,903 |
| 93.398 |
Cancer Misinformation and Use of Complementary and Alternative Therapy (cam) Among Patients with Cancer |
$84,184 |
| 84.007 |
Federal Supplemental Education Opportunity Grant Program - Jfk Muhlenberg School |
$80,000 |
| 93.855 |
C5a/c5ar1 Signaling in Protective Immunity During Invasive Candidiasis |
$78,616 |
| 93.855 |
Modulating Costimulation Pathways to Improve Follicular Helper T Cell and Antibody Responses |
$69,520 |
| 93.940 |
Integrated Hiv Programs |
$67,000 |
| 93.855 |
Serine/threonine Kinase Signaling in Beta-Lactam Resistance of Staphylococcus Aureus |
$63,902 |
| 93.395 |
Mosaic: Rct of A Digital Health Intervention Delivering Peer Support Narratives and Psychoeducation to English and Spanish-Speaking Stem Cell Transplant Recipients |
$56,983 |
| 93.855 |
Combatting Natural Resistance and Persistence in Non-Tb Mycobacterial Disease |
$56,683 |
| 93.395 |
Lncrna Epic1 Induces Immunotherapy Resistance by Activating Ezh2 in Breast Cancer |
$47,437 |
| 93.433 |
The Traumatic Brain Injury Model Systems National Data and Statistical Center |
$38,700 |
| 93.393 |
Bridging Information Divides and Gaps to Ensure Survivorship |
$37,960 |
| 93.917 |
Ryan White Title B |
$33,288 |
| 93.855 |
Ezh2 Regulates Follicular Helper T Cell Differentiation |
$32,908 |
| 93.846 |
Stopping Hydrochloroquine in Elderly Lupus Disease (shield) |
$32,790 |
| 93.855 |
Synthesizability-Constrained Expansion and Multi-Objective Evolution of Antitubercular Compounds |
$31,469 |
| 12.420 |
Engaging Retiring Military Personnel in Va Lung Cancer Screening Through Codesigned Communication Campaign |
$30,858 |
| 93.393 |
Multilevel Interventions to Increase Adherence to Lung Cancer Screening |
$26,707 |
| 93.994 |
Special Child Health Child Evaluation Centers 2024 |
$25,567 |
| 93.855 |
Antibiotic Resistance Among Hypermutator Carbapenem Resistant Klebsiella Pneumoniae |
$25,366 |
| 93.153 |
Ryan White Part D |
$23,414 |
| 93.994 |
Special Child Health Child Evaluation Centers 2025 |
$23,405 |
| 93.397 |
Epigenetic Therapies - New Approaches, Pathology Core |
$20,977 |
| 93.855 |
Novel Dual-Stage Antimalarials: MacHine Learning Prediction, Validation and Evolution |
$20,886 |
| 93.243 |
Expanded Interprofessional Medication-Assisted Treatment Training Program |
$19,943 |
| 93.397 |
Georgetown University Lombardi Cancer Center Support Grant - Improve Efficacy of Car-T Cells in Treatment of Pdac |
$18,243 |
| 93.855 |
Defining Stim1 Function at the Immunological Synapse |
$16,196 |
| 93.866 |
Escitalopram in Agitation in Alzheimer Disease |
$15,728 |
| 93.393 |
Bridging Information Divides and Gaps to Ensure Survivorship; the Bridges Randomized Controlled Trial of Multilevel Intervention to Improve Adherence to Childhood Cancer Survivorship |
$15,000 |
| 93.397 |
Fit & Quit 2.0: Feasibility and Usability Testing |
$14,077 |
| 93.393 |
Empathic Communication Skills Training to Reduce Lung Cancer Stigma |
$13,305 |
| 93.837 |
Role of Lsd1 in Triple Negative Breast Cancer Development and Therapeutic Response |
$11,898 |
| 93.226 |
Simulation to Improve Infection Prevention and Patient Safety: the Sipps Trial |
$10,016 |
| 93.866 |
Use of the Kf Modified Story Memory Technique to Improve New Learning and Memory in Individuals with Mild Cognitive Impairment |
$6,500 |
| 93.865 |
The Patient Journey for Children with Medical Complexity During the Pandemic Era and Its Implications |
$5,860 |
| 93.394 |
Uncover: Underlying Novel Causes of Onset of Very Early Cancer Research |
$3,983 |
| 93.855 |
Bacterial Characteristics of Community-Associated Carbepenem-Resistant Enterobacteriaceae |
$3,047 |
| 12.420 |
Host-Directed Approaches to Target Granuloma Pathways for Treatment Shortening in Tuberculosis |
$1,263 |